Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population

dc.article.end-page3117en
dc.article.start-page3110en
dc.citation.doi10.1093/JAC/DKAC290en
dc.contributor.authorR Grieselen
dc.contributor.authorP Sinxadien
dc.contributor.authorA Kawumaen
dc.contributor.authorJ Joskaen
dc.contributor.authorSimiso Sokhelaen
dc.contributor.authorGodspower Akpomiemieen
dc.contributor.authorWillem Venteren
dc.contributor.authorE et alen
dc.date.accessioned2024-07-23T05:54:13Z
dc.date.available2024-07-23T05:54:13Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn0305-7453en
dc.identifier.urihttps://hdl.handle.net/10539/39030
dc.journal.titlePharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African populationen
dc.journal.volume77en
dc.publisherOXFORD UNIV PRESSen
dc.titlePharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African populationen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
1.53 MB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client